Cancer Patients With Solid Tumors

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Elevar Therapeutics
Elevar TherapeuticsKorea - Seoul
1 program
1
YN968D1Phase 1/21 trial
Active Trials
NCT01497704Completed55Est. May 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Elevar TherapeuticsYN968D1

Clinical Trials (1)

Total enrollment: 55 patients across 1 trials

Dose-Escalation and Safety Trial of YN968D1

Start: Apr 2012Est. completion: May 201555 patients
Phase 1/2Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space